These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15068018)

  • 1. Oral HIV test approved by FDA.
    Lancet; 2004 Apr; 363(9415):1125. PubMed ID: 15068018
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 viral load test approved by FDA.
    AIDS Patient Care STDS; 2007 Jun; 21(6):438-9. PubMed ID: 17594254
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves OraQuick for use in saliva. On March 25, the FDA approved the first rapid test for HIV in oral fluids.
    Branson BM
    AIDS Clin Care; 2004 May; 16(5):39. PubMed ID: 15199863
    [No Abstract]   [Full Text] [Related]  

  • 4. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves first oral HIV antibody test. Food and Drug Administration.
    AIDS Alert; 1996 Aug; 11(8):94. PubMed ID: 11363658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA device approval regulations.
    Savage RA
    Hum Pathol; 1994 May; 25(5):548-9. PubMed ID: 8200653
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves early test.
    AIDS Patient Care STDS; 2006 Nov; 20(11):814. PubMed ID: 17134356
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA statutory authority to regulate the safety of dietary supplements.
    Hutt PB
    Am J Law Med; 2005; 31(2-3):155-74. PubMed ID: 16146287
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA regulatory compliance reconsidered.
    Tobias C
    Cornell Law Rev; 2008 Jul; 93(5):1003-38. PubMed ID: 18618969
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid diagnostic testing for HIV. Clinical implications.
    Paul SM; Grimes-Dennis J; Burr CK; DiFerdinando GT
    N J Med; 2002 Sep; 99(9):20-4, quiz 24-6. PubMed ID: 12244703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HIV-1 RNA test following a reactive fourth-generation antigen/antibody combination assay confirms a high proportion of HIV infections.
    Westheimer E; Fu J; Radix A; Giancotti FR; Hall L; Daskalakis DC; Tsoi B; Peters PJ
    J Clin Virol; 2014 Dec; 61(4):623-4. PubMed ID: 25453336
    [No Abstract]   [Full Text] [Related]  

  • 12. Injured consumers and the FDA. Should federal preemption protect medical device manufacturers under a quasi-governmental immunity?
    Truitt BI
    J Leg Med; 1994 Mar; 15(1):155-84. PubMed ID: 8201276
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding FDA regulation of DTC genetic tests within the context of administrative law.
    Wagner JK
    Am J Hum Genet; 2010 Oct; 87(4):451-6. PubMed ID: 20920664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL
    Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves "instant" HIV home test.
    Roehr B
    BMJ; 2012 Jul; 345():e4636. PubMed ID: 22767643
    [No Abstract]   [Full Text] [Related]  

  • 16. Dirty dancing--the FDA stumbles with the Chevron two-step: a response to professor Noah.
    Lawson G
    Cornell Law Rev; 2008 Jul; 93(5):927-38. PubMed ID: 18618964
    [No Abstract]   [Full Text] [Related]  

  • 17. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 Sep; 276(10):774. PubMed ID: 8769577
    [No Abstract]   [Full Text] [Related]  

  • 18. A proposal concerning products liability.
    Nusbaum NJ
    N Y State J Med; 1989 Jul; 89(7):396-9. PubMed ID: 2761867
    [No Abstract]   [Full Text] [Related]  

  • 19. Deadly dimethylamylamine: "health" supplements are killing consumers while current regulations impede FDA action.
    Palmer PG
    J Leg Med; 2014; 35(2):311-36. PubMed ID: 24896317
    [No Abstract]   [Full Text] [Related]  

  • 20. The Personal Care Products Safety Act.
    Feinstein D; Collins S
    JAMA Intern Med; 2018 May; 178(5):601-602. PubMed ID: 29404567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.